期刊文献+

老年革兰阴性杆菌性肺炎的病原菌耐药性分析 被引量:9

Distribution and drug resistance of gram-negative bacilli causing pneumonia in senile patients
原文传递
导出
摘要 目的探讨基层医院老年革兰阴性杆菌性肺炎的病原菌构成比及耐药性,为临床医师合理使用抗菌药物提供科学依据。方法细菌培养鉴定按照《全国临床检验操作规程》进行;药敏试验采用CLSI推荐的K-B法。结果老年肺炎患者分离的158株革兰阴性杆菌主要为铜绿假单胞菌、肺炎克雷伯菌、大肠埃希菌、阴沟肠杆菌,分别占31.0%、25.9%、20.9%、12.0%;以上细菌对常用抗菌药物均产生了较严重的耐药性,铜绿假单胞菌甚至对碳青霉烯类抗菌药物亚胺培南、美罗培南也产生了耐药性,耐药率为14.3%、18.4%。结论基层医院医院感染的病原菌耐药性呈上升趋势,应采取综合性预防与控制措施。 OBJECTIVE To explore constitution ratio and antimicrobial resistance of gram-negative bacilli causing pneumonia in senile patients in a grass-root hospital and provide the scientific evidence for clinicians to rationally use antibiotics. METHODS Referring to National Guide to Clinical Laboratory Procedure,the pathogenic bacteria were cultured and identified.The antibiotic susceptibility testing was performed by K-B method recommended by CLSI. RESULTS Totally 158 strains of gram negative bacilli were isolated from senile patients with pneumonia,mostly including Pseudomonas aeruginosa(31.0%),Klebsiella pneumoniae(25.9%),Escherichia coli(20.9%) and Enterobacter cloacae(12.0%).The above strains had developed serious resistance to commonly used antibiotics.Resistance rates of Pseudomonas aeruginosa to carbapenems antibiotics imipenem and meropenem were 14.3% and 18.4%,respectively. CONCLUSION The comprehensive prevention and control measures should be adopted to restrain the increasing tendency of bacterial resistance in grass-root hospitals.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第3期622-623,共2页 Chinese Journal of Nosocomiology
关键词 老年患者 医院肺炎 革兰阴性杆菌 耐药性 Senile patients Hospital acquired pneumonia Gram-negative bacilli Antimicrobial resistance
  • 相关文献

参考文献3

二级参考文献28

共引文献65

同被引文献59

  • 1余娴,凌保东,雷军.某院产超广谱β-内酰胺酶临床分离革兰阴性杆菌的耐药性及基因型分析[J].中国药房,2007,18(1):25-27. 被引量:12
  • 2王扬,夏丽萍,康健,李艳玲,王琨,阎雪.β-内酰胺类抗菌药物对阴沟肠杆菌AmpC酶的诱导性研究[J].中华医院感染学杂志,2007,17(2):125-128. 被引量:13
  • 3中华人民共和国卫生部.医院感染诊断标准[S].北京:中华人民共和国卫生部,2001:7-8.
  • 4中华人民共和国卫生部.医院感染诊断标准[S].北京:中华人民共和国卫生部,2001.1-35.
  • 5Clinical and laboratory Standards Institute.Performance Standardsfor Antimicrobial Susceptibility testing[S].M100-S20.CLSI,2010.
  • 6Yang FC,Yan JJ,Hung KH,et al.Characterization of er-tapenem-resistant Enterobacter cloacae in a Taiwan Residents univer-sity hospital[J].J Clin Microbiol,2012,50(2):223-226.
  • 7Clinical and laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing[S]. M100-S20. CLS1, 2010.
  • 8Liu YM,Chen YS,Toh HS, et al. In vitro susceptibilities of non Enterobacteriacese isolates from patients with intra-abdominal infectionns in the Asia-Pacific region fron 2003 to 2010: results from the study for monnitoring Antimicrobail Resistance Trends (SMART) [J]. Int J Antimicrob Agents, 2012, 40 (Suppl): sl 1-sl 7.
  • 9Lo W T,LinWJ,ChiuehTS,etal.Changingtrendsinantimi-crobialresistanceofmajorbacterialpathogens,1985-2005:astudyfromamedicalcenterinnorthernTaiwan[J].JMicrobiolImmunolInfect,2011,44(2):131-138.
  • 10Pfeifle D,JanasE,Wiedemann B.Roleofpenicillin-bindingproteinsintheinitiationoftheAmpCbeta-lactamaseexpres-sioninEnterobactercloacae[J].AntimicrobAgentsChemoth-er,2000,44(1):169-172.

引证文献9

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部